Copper(less) Committee

MIA's scientific advisory body, established March 2021. A multidisciplinary team of scientists, physicians, pharmacists and families working pro bono.

Mission

The Copper(less) Committee was established in March 2021 as the scientific advisory body of MIA. Its founding purpose was to develop the first dosing plan for human use for the exceptional treatment with elesclomol-copper (Es-Cu) for Menkes patients.

The committee comprises scientists, researchers, medical doctors, pharmacometricians, pharmacists, chemists, biologists and family members. All serve on a pro bono basis.

Elesclomol-Copper (Es-Cu) Exceptional Treatments

The committee develops and oversees the dosing plan for elesclomol-copper exceptional treatment for authorised patients — the first such protocol for human use.

Early Diagnosis Protocols

Developing and disseminating clinical protocols to improve early diagnosis of Menkes disease, including the bilingual brochure distributed to paediatricians worldwide.

Ongoing Research Projects

Members contribute to active research initiatives across genetics, pharmacology, biochemistry and clinical care.

Weekly Scientific Meetings

The committee meets every Friday at 16:00 CET to review cases, discuss treatment options and coordinate new initiatives.

Early Diagnosis Brochure

Produced by the Copper(less) Committee — available in English

Download PDF

Rules of Procedure

Internal operating rules of the Copper(less) Committee (signed)

Download PDF

NPP-Menkes — Free Treatment Program

Named-Patients Program with Elesclomol-Copper. 9 children treated in Spain and Switzerland. Treatment provided completely free of charge.

Learn more

Committee Members

Census 2026

Francesc Palau

Francesc Palau

Chair

Pediatrician & Medical Geneticist, CSIC Research Professor · SJD Distinguished Investigator, Sant Joan de Déu Hospital and Research Institute

Barcelona, Spain

Vishal M. Gohil, Ph.D.

Vishal M. Gohil, Ph.D.

Vice-Chair

Professor and Chancellor EDGES Fellow, Dept. of Biochemistry and Biophysics · IHA Affiliate Member, Texas A&M University

College Station, TX, USA

Denis Broun

Denis Broun

Rapporteur

Medical Director, Menkes International · Former WHO and World Bank Director · CEO, Givopax

Aurora Mateos

Aurora Mateos

Secretary

Founder & President, Menkes International – Copper Rare Foundation

Málaga, Spain

FR

Flor Rolleri

Technical Secretary

Medical Doctor, Servicio Valenciano de Salud · Menkes International – Copper Rare Foundation

CopperClinic

Reference physicians and clinicians, reporting to the Copper(less) Committee